As showed in Table 1, in group “severe” pneumonia and hypertension rate was statistically significantly higher (p = 0.005 and p = 0.015 respectively) as compared to group “mild.” Furthermore the use of ACE inhibitors was more frequent in patients with severe outcome (p = 0.035). This evidence concerns the gene ACE and pneumonia.